JP4674286B2 - Emulsifiers and cosmetics - Google Patents
Emulsifiers and cosmetics Download PDFInfo
- Publication number
- JP4674286B2 JP4674286B2 JP2002302998A JP2002302998A JP4674286B2 JP 4674286 B2 JP4674286 B2 JP 4674286B2 JP 2002302998 A JP2002302998 A JP 2002302998A JP 2002302998 A JP2002302998 A JP 2002302998A JP 4674286 B2 JP4674286 B2 JP 4674286B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- lactic acid
- acid bacteria
- emulsifier
- cosmetics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、良好な乳化作用を有し、しかも低毒性で皮膚刺激が少ないなど安全性にすぐれ、化粧料や外用医薬品、さらには食品など広汎な商品分野に於ける乳化物の調製に用いて好適な乳化剤並びにこれを配合し或いは用いてなる化粧料及び外用医薬品に関する。
【0002】
【従来の技術】
化粧料や外用医薬品の乳化には、ポリオキシエチレンアルキルエーテル、ソルビタン脂肪酸部分エステルなどの合成界面活性剤が主として用いられている。
しかしながら、合成界面活性剤の場合は、程度の差こそあれ皮膚に対する刺激作用が避けられず、このため活性剤の使用量を極力減らしたり、又場合によってはこれを用いないで乳化を行うことが試みられているが、乳化の均一性や経時安定性の点で問題を生ずるケースが多く、必ずしも満足できる結果は得られていない。
【0003】
【発明が解決しようとする課題】
これに対して、サポニン、レシチン、ステビオシド等の天然物由来成分を乳化剤として用いることにより、皮膚に対する安全性の高い乳化物を調製することが提案され、現に一部実用化されているが、乳化安定性、皮膚適用時の使用感、製造の容易さ等の点で必ずしも十分とは言い難い面があり、さらなる改善が求められている。
本発明者らは、かかる従来技術の問題点に対して、先に米を乳酸菌で醗酵して得られる乳酸菌醗酵米が、すぐれた乳化作用、乳化安定化作用と高い生体安全性を具え、化粧料等の乳化に用いて極めて有用なものであることを明らかにしたが、さらに広く天然物由来成分中に乳化剤となり得るものを見出すべく研究と探索を進めた結果、雑穀類の乳酸菌醗酵物が同様に良好な乳化作用と生体安全性とを有し、化粧料や外用医薬品、さらには食品など広汎な分野に於いて乳化剤として用い得ることを知得し、本発明を完成した。
【0004】
【課題を解決するための手段】
即ち、本発明は、大麦、小豆、キビ及びヒエから選ばれた一種又は二種以上を乳酸菌で醗酵させて得られる乳酸菌醗酵物の固相部からなる乳化剤、並びに該乳酸菌醗酵物の固相部を配合してなる化粧料又は外用医薬品に関するものである。
なお、本発明に於いて化粧料とは、いわゆる化粧品のほかに医薬部外品をも含む意味で用いる。又、以下に於いては乳酸菌醗酵物の固相部を単に乳酸菌醗酵物ということがある。
【0005】
【発明の実施の形態】
以下、本発明について詳細に説明する。
乳酸菌醗酵の被醗酵物として用いる雑穀類としては、例えば大麦、小麦、えん麦、ハト麦、カラス麦、裸麦、ライ麦などの麦類、大豆、黒大豆、小豆、いんげん豆、手亡豆、大福豆、うずら豆、えんどう豆、レンズ豆、白花豆、赤花豆、トラ豆、緑豆、ヒヨコ豆、そら豆、樹豆などの豆類、アワ、キビ、ヒエ、ソバ、アマランサス、トウモロコシなどの雑穀等が挙げられる。
それらのうちでも、乳酸菌醗酵物の乳化能或いは原料品質の安定性等の観点から、麦類としては大麦、小麦及びハト麦が、豆類としては大豆及び小豆が、又雑穀としてはアワ、キビ、ヒエ及びトウモロコシが好ましく、特に大麦、小豆、キビ及びヒエが最も好ましい。従って、本発明に於いては大麦、小豆、キビ及びヒエの4種が用いられる。
なお、本発明に於いては、上述の雑穀類の発芽物、例えば発芽大豆、発芽大麦等を被醗酵物として用いることも可能であり、それらの発芽物によっても同じく良好な乳化作用を示す乳酸菌醗酵物を得ることができる。
本発明の乳酸菌醗酵物を調製するに当たっては、上記した雑穀類の種子のうちのいずれか一種を用いるのが一般的であるが、場合によっては二種以上の種子を混合して用いてもよい。
【0006】
雑穀類の醗酵に用いる乳酸菌としては、例えば、ラクトバチルス プランタラム(Lactobacillus plantarum)、ラクトバチルス ブレビス(L.brevis)、ラクトバチルス カゼイ(L.casei)、ラクトバチルス セロビオサス(L.cellobiosus)、ラクトバチルス バシノステルカス(L.vaccinostercus)、ストレプトコッカス フェーカリス(Streptococcus faecalis)、バチルス コアギュランス(Bacillus coagulans)等があるが、得られる乳酸菌醗酵物の乳化能等の観点からは、ラクトバチルス プランタラム(Lactobacillus plantarum)又はストレプトコッカス フェーカリス(Streptococcus faecalis)の使用が特に好ましい。
【0007】
それら乳酸菌による雑穀類の醗酵は、例えば以下のようにして行われる。
まず雑穀類の種子に、水洗、エタノール処理等適宜の手段を施して、乳酸菌醗酵の障害となる雑菌を除去する。この種子を、その1〜5倍量の精製水に浸漬し、これに糖質1〜4重量%と乳酸菌107 〜108 個/mlを添加して、嫌気性条件下、用いた乳酸菌の至適醗酵温度付近で2〜10日間醗酵を行わしめる。
糖質としては、グルコース、フルクトース、ガラクトース、シュークロース等が使用されるが、なかでもフルクトースの使用が最も好ましい。また、糖質に代えて酵母エキス、麦芽エキス等を用いてもよい。
【0008】
上記の醗酵工程によって得られる雑穀類の乳酸菌醗酵物を含む液は、これをそのまま摩砕工程に付し、必要により濃縮を行って化粧料等に配合してもよいが、より一般的には乳酸菌醗酵物を醗酵液から分取し、水洗した後、要すれば水分調整を行った上、ミキサー粉砕、ロール粉砕、気流粉砕等適宜の粉砕手段を用いて粉砕し、必要ならば乾燥処理、さらには篩い分けを行って、化粧料等の乳化剤として供する。
【0009】
以上の如くして得られる雑穀類の乳酸菌醗酵物からなる本発明の乳化剤を化粧料等に配合乃至は適用する場合、該醗酵物はそれ単独で十分なる乳化力を具え、得られる乳化物は実用上十分満足し得る乳化安定性を示すが、該醗酵物にさらに増粘剤を組み合わせ用いることにより、乳化物の安定性を一層向上せしめることができる。
【0010】
ここで増粘剤としては、化粧料等に通常用いられているものが使用可能であり、具体的には、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;ペクチン、ローカストビーンガム等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸又はその誘導体、ポリグルタミン酸又はその誘導体などが挙げられる。
それらのうちでも、乳化安定性の観点、さらには本発明の乳酸菌醗酵物の特長である高い生体安全性を損なわないという観点から、特にヒアルロン酸又はその誘導体、ポリグルタミン酸又はその誘導体、キサンタンガム或いはトラガントガムの使用が好ましく、又アルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来の成分も好適に使用できる。
【0011】
それら増粘剤を併用する場合、その使用量は、用いる増粘剤の種類によっても異なるが、一般には乳酸菌醗酵物の固形分100重量部に対して、固形分で1〜100重量部の範囲、好ましくは5〜50重量部の範囲であり、かかる範囲から乳化物の用途、要求性能等を勘案して、最適のものを選択する。
【0012】
乳酸菌醗酵物との併用に当たって増粘剤は、所定の比率で予め乳酸菌醗酵物と混合して使用してもよく、又乳酸菌醗酵物を用いて化粧料等の乳化を行う際、該醗酵物の添加前又は後に、もしくは該醗酵物と同時に乳化系に添加するようにしてもよい。場合によっては乳化後に添加することもできる。
【0013】
本発明の雑穀類の乳酸菌醗酵物からなる乳化剤は、良好な乳化作用を具え、安定性に富んだ乳化物を与えると共に、低毒性で皮膚への刺激が極めて少ないなど人体に対する安全性にすぐれ、化粧料や外用医薬品、さらには食品、農薬など広汎な分野に於ける乳化物の調製に用いて有用である。
なかでも、化粧料や外用医薬品用の乳化剤として用いた場合には、乳酸菌醗酵物の有する高い保水・保湿性と皮膚に対する密着性の故に、得られる化粧料等の皮膚に対する感触、使用感が極めて良好なものとなるとの利点もある。
従って本発明によれば、上述の雑穀類の乳酸菌醗酵物を含み、乳化安定性と生体安全性、さらには使用感にすぐれた化粧料及び外用医薬品が提供される。
【0014】
雑穀類の乳酸菌醗酵物を配合してなる本発明の化粧料としては、例えば乳液、クリーム、ローション、エッセンス、パックなどの基礎化粧品;口紅、ファンデーション、リクイドファンデーション、メイクアッププレスパウダーなどのメイクアップ化粧品;洗顔料、シャンプー、リンスなどの清浄用化粧品;ヘアートリートメント、コンディショナー、ヘアークリーム、染毛料、整髪料などの頭髪化粧品;歯磨き、マウスウオッシュなどの口腔化粧品;浴剤及び各種剤形からなる医薬部外品などが挙げられる。
又、雑穀類の乳酸菌醗酵物を配合してなる本発明の外用医薬品としては、例えばクリーム、乳液、ローションなどがある。
【0015】
本発明の雑穀類の乳酸菌醗酵物を化粧料に配合する場合の配合量は、化粧料の種類等によっても異なるが、例えば、基礎化粧品、メイクアップ化粧品、頭髪化粧品及び医薬部外品の場合であれば、一般に0.5〜20重量%(乳酸菌醗酵物の固形分として。以下同じ)、好ましくは2〜10重量%の範囲、清浄用化粧品の場合であれば、一般に1〜30重量%、好ましくは5〜20重量%の範囲、又口腔化粧品の場合であれば、一般に0.5〜20重量%、好ましくは2〜10重量%の範囲である。
外用医薬品への配合量は、例えばクリームや乳液或いはローションの場合であれば、一般に0.5〜20重量%、好ましくは2〜10重量%の範囲である。
乳酸菌醗酵物の配合に当たって、増粘剤を組み合わせ用いるのであれば,乳酸菌醗酵物の配合量を上記の単独使用の場合の40〜80%に低減することができる。
【0016】
なお、本発明の雑穀類の乳酸菌醗酵物を化粧料等に配合するに当たって、該乳酸菌醗酵物に予め親水性物質、特に糖類及びグリコール類から選ばれた1種又は2種以上を混和した場合、該乳酸菌醗酵物の水に対する馴染み・分散性が改善され、化粧料等への配合が容易となって好ましい。
【0017】
この場合糖類としては、例えばグルコース、フルクトース、アラビノース、ガラクトースなどの単糖類;シュークロース、ラクトース、マルトース、トレハロースなどの二糖類;フラクトオリゴ糖、キシロオリゴ糖、マルトオリゴ糖などの少糖類;ソルビトール、マルチトール、キシリトールなどの糖アルコール類等が使用できる。
【0018】
又グリコール類としては、例えばグリセリン、プロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコールなどがある。
【0019】
それら糖類及び/又はグリコール類(以下、混和成分ということがある)のうちでも、乳酸菌醗酵物の水に対する馴染み・分散性の改善効果の点からは、糖類の使用が好ましく、糖類のうちでも糖アルコール類の使用が最も好ましい。。
【0020】
又、分散性改善効果は、乳酸菌醗酵物と糖類及び/又はグリコール類との混和物が水もしくは液体状物質によって湿潤状態にあるとき、より効果的に発現されることから、混和成分として糖類を用いる場合には、それらを水溶液の形で乳酸菌醗酵物に配合する方法等によって、得られる混和物を、水分率が10〜40重量%、特に15〜30重量%の範囲の湿潤状態とすることが好ましい。
一方、常温で液体状であるグリセリン、1,3−ブチレングリコールなどのグリコール類を使用する場合は、グリコール自身の特性に基づいて混和物を湿潤状態とすることが可能であり、水の使用は必ずしも必要でないが、場合によってはこれを併用してもよい。
【0021】
乳酸菌醗酵物に対する糖類或いはグリコール類の配合量は、それら成分のいずれの場合も、乳酸菌醗酵物(固形分)100重量部に対して、固形分で一般に5〜50重量部、好ましくは10〜40重量部の範囲である。
【0022】
乳酸菌醗酵物と糖類及び/又はグリコール類との混和物を調製する方法としては、乳酸菌醗酵物に所定量の混和成分を添加し、適宜の混合手段を用いて均一な混和物とする方法など常法に従って行えばよく特に制限はないが、混和成分として単糖、糖アルコールなど常温で固体状の物質を用いる場合には、混和物の分散性改善効果をより効果的に発現せしめるため、前記した通り、それら混和成分を水溶液の形で乳酸菌醗酵物と混和するようにするか、もしくは場合によっては粉末状のまま混和した後水を添加することにより、混和物の水分率を所望の値に調整することが好ましい。
【0023】
以上の如くして得られる混和物を化粧料等に配合する場合、その水に対する馴染み・分散性改善の結果として、配合作業性さらには得られる製品の均質性が大幅に改善されることは既に述べた通りであるが、本発明の雑穀類の乳酸菌醗酵物は、乳酸菌醗酵の特性上、水に分散・溶解せしめた時酸性を示すため、化粧料等への配合に当たって、場合によってはなお中和工程が必要となるケースも考えられる。
かかる工程上の煩雑さを解消し、作業性、取り扱い性のより改良された混和物とするため、これにさらにアルカリ性物質を配合するようにしてもよい。
【0024】
この場合、アルカリ性物質としては、例えば水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、水酸化マグネシウムなどのアルカリ金属或いはアルカリ土類金属の水酸化物;炭酸、クエン酸、リン酸などの弱酸のアルカリ金属塩;エタノールアミン、ジエタノールアミン、トリエタノールアミン、イソプロパノールアミンなどのアミン類;アルギニン、リジン、ヒスチジンなどの塩基性アミノ酸類;アンモニア水、アミノメチルプロパノール、アミノメチルプロパンジオールなどが挙げられる。
【0025】
これらアルカリ性物質の配合量は、用いるアルカリ性物質の種類等によって異なるが、一般には、組成物の10重量%水分散液或いは水溶液の示すpHが5.5〜7.5の範囲となるような量とするのがよい。
【0026】
本発明の雑穀類の乳酸菌醗酵物を配合した化粧料や外用医薬品を調製する場合、その構成成分としては、通常化粧料等に用いられる成分、例えば油性成分、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香料、生理活性成分、薬剤等を適宜使用することができる。又、必要ならば界面活性剤を併用してもよい。
【0027】
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボカド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。
【0028】
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、乳酸菌醗酵米、ヒアルロン酸及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、ビャッキュウ抽出物、海藻抽出物、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体が挙げられる。
【0029】
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻或いは紅藻由来成分、ビャッキュウ抽出物、ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類、キサンタンガム、トラガントガム、グアーガム等のガム類、カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体、ポリグルタミン酸及びその誘導体等が挙げられる。
【0030】
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。
【0031】
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、シルクパウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。
【0032】
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。
【0033】
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体、各種ポリフェノール類、ビャッキュウ抽出物、イネ抽出物等がある。
【0034】
生理活性成分としては、例えば美白成分として、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、アルブチン及びその誘導体、エラグ酸及びその誘導体、レゾルシノール誘導体、ソウハクヒ抽出物、ユキノシタ抽出物、米糠抽出物、米糠抽出物の加水分解物、白芥子加水分解抽出物、ムラサキシキブ抽出物、コンブ等の海藻の抽出物、アマモ等の海草の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、2,5−ジヒドロキシ安息香酸誘導体等が、皮膚老化防止・肌荒れ改善成分として、動物又は魚由来のコラーゲン、ニコチン酸及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、ビタミンE及びその誘導体、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナエキス、甘草エキス、ハトムギエキス、カミツレエキス、ニンジンエキス、アロエエキスなどの生薬抽出エキス、米抽出物加水分解物、米糠抽出物加水分解物、米醗酵エキス、ミツイシコンブ抽出物、アマモ等の海草の抽出物、ソウハクヒエキス等がある。
【0035】
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド(2−O−α−D−グルコピラノシル−L−アスコルビン酸)、L−アスコルビン酸−5−グルコシド(5−O−α−D−グルコピラノシル−L−アスコルビン酸)などのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類等が、レゾルシノール誘導体としては、例えば4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、ビタミンE誘導体としては、例えばビタミンEニコチネート、ビタミンEリノレート等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。
【0036】
薬剤としては、アミノ安息香酸エチル、インドメタシン、ヘパリンナトリウム、サリチル酸メチルなどの消炎鎮痛・鎮痒剤;ヒドロコルチゾン、デキサメタゾン、フルオシノロンアセトニド、プレドニゾロンなどの副腎皮質ホルモン抗炎症剤;塩化ベンザルコニウム、塩化ベンゼトニウム、クロルヘキシジン、スルファジアジンなどの殺菌剤;エリスロマイシン、テトラサイクリン、クロラムフェニコール、トリコマイシンなどの抗生物質殺菌剤;クロトリマゾール、トルナフテート、硝酸ミコナゾール、ケトコナゾールなどの抗真菌剤;ジフェンヒドラミン、マレイン酸クロルフェニラミン、塩酸イソチペンジル、フマル酸クレマスチンなどの抗ヒスタミン剤;尿素、サリチル酸、ビタミンA、ビタミンE、ビタミンC、ビタミンB6などの肌荒れ改善剤等が挙げられる
【0037】
なお、前述の通り、界面活性剤は必ずしもこれを併用する必要はないが、仮に併用する場合には、ショ糖脂肪酸エステル、レシチン及びその誘導体、酵素処理ステビアなどの生体安全性にすぐれた活性剤を少量用いることが好ましい。
【0038】
次に、実施例、処方例(化粧料及び外用医薬品の実施例)及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下に於いて、部はすべて重量部を、また%はすべて重量%を意味する。
【0039】
実施例1.乳化剤の調製(1)
ハト麦1Kgを70%エタノールに一晩浸漬して殺菌し、次いで濾過によりハト麦を分取した後、これにボイル殺菌した水2Lを加えて洗浄する操作を3回繰り返して、エタノールを十分に除去した。
殺菌したハト麦に、ボイル殺菌した0.1%酵母エキス溶液3Lを加えた後、これに、予めGYP培地で前培養(37℃、3日間)しておいた乳酸菌(S.faecalis)培養液を、乳酸菌の濃度が108個/0.1%酵母エキス1mlとなる量だけ加え、窒素雰囲気下に37℃で3日間培養した。
培養終了後、金網で粗ろ過してハト麦の乳酸菌醗酵物を分取し、これを流水で洗浄して付着した培養液を十分に洗い流した後、60℃、通風の条件下に、水分率が約15%以下となるまで乾燥させた。次に、この乾燥物をミキサー粉砕した後篩い分け(90μm、166メッシュ)して、ハト麦の乳酸菌醗酵物を微粉末として得た(収量920g、水分率12.5%)。
【0040】
実施例2.乳化剤の調製(2)
乳酸菌としてS.faecalisに代えてL.plantalumを用いるほかは実施例1と同様の操作を行い、ハト麦の乳酸菌醗酵物を微粉末として得た(収量910g、水分率12.4%)。
【0041】
実施例3.乳化剤の調製(3)
ハト麦に代えて大麦を用いるほかは実施例1と同様の操作を行い、大麦の乳酸菌醗酵物を微粉末として得た(収量580g、水分率12.0%)。
【0042】
実施例4.乳化剤の調製(4)
ハト麦に代えてアワを用いるほかは実施例1と同様の操作を行い、アワの乳酸菌醗酵物を微粉末として得た(収量880g、水分率12.8%)。
【0043】
実施例5.乳化剤の調製(5)
ハト麦に代えてキビを用いるほかは実施例1と同様の操作を行い、キビの乳酸菌醗酵物を微粉末として得た(収量890g、水分率12.4%)。
【0044】
実施例6.乳化剤の調製(6)
ハト麦に代えてヒエを用いるほかは実施例1と同様の操作を行い、ヒエの乳酸菌醗酵物を微粉末として得た(収量900g、水分率12.0%)。
【0045】
実施例7.乳化剤の調製(7)
ハト麦に代えて大豆を用いるほかは実施例1と同様の操作を行い、大豆の乳酸菌醗酵物を微粉末として得た(収量920g、水分率13.2%)。
【0046】
実施例8.乳化剤の調製(8)
ハト麦に代えて小豆を用いるほかは実施例1と同様の操作を行い、小豆の乳酸菌醗酵物を微粉末として得た(収量780g、水分率12.5%)。
【0047】
実施例9.乳化剤の調製(9)
大豆を水洗し、3倍量の水に一晩浸漬した後、水切りした。これを湿潤状態に30℃で2日間保持して発芽させ、発芽した大豆を60℃で一晩乾燥した。
この乾燥発芽大豆1Kgを70%エタノールに一晩浸漬して殺菌し、次いで濾過により発芽大豆を分取した後、これにボイル殺菌した水2Lを加えて洗浄する操作を3回繰り返して、エタノールを充分に除去した。
殺菌した発芽大豆に、ボイル殺菌した0.1%酵母エキス溶液3Lを加えた後、これに、予めGYP培地で前培養(37℃、3日間)しておいたた乳酸菌(S.faecalis)培養液を、乳酸菌の濃度が108個/0.1%酵母エキス1mlとなる量だけ加え、窒素雰囲気下に37℃で3日間培養した。
培養終了後、金網で粗ろ過して発芽大豆の乳酸菌醗酵物を分取し、これを流水で洗浄して付着した培養液を十分に洗い流した後、60℃、通風の条件下に、水分率が約15%以下となるまで乾燥させた。次に、この乾燥物をミキサー粉砕した後篩い分け(90μm、166メッシュ)して、発芽大豆の乳酸菌醗酵物を微粉末として得た(収量890g、水分率13.5%)。
【0048】
実施例10.乳化剤の調製(10)
大豆に代えて大麦を用いるほかは実施例9と同様の操作を行い、発芽大麦の乳酸菌醗酵物を微粉末として得た(収量880g、水分率12.8%)。
【0049】
実施例11.乳化剤組成物の調製(1)
実施例1と同様に操作して得られたハト麦の乳酸菌醗酵物の微粉末800gにマルチトール液(70%マルチトール水溶液)200gを加え、練合機で練合・混和して均一な混和物を得た(水分率14.6%)。
【0050】
実施例12.乳化剤組成物の調製(2)
マルチトール液200gに代えてグリセリン200gを用いるほかは実施例11と同様に操作して均一な混和物を得た(水分率12.4%)。
【0051】
実施例13.乳化剤組成物の調製(3)
実施例1と同様に操作して得られたハト麦の乳酸菌醗酵物の微粉末785gにマルチトール液200gとアルギニン15gを加え、練合機で練合・混和して均一な混和物を得た(水分率15.1%)。
【0052】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質なクリームを得た。
【0053】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0054】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳白色の化粧水を得た。
【0055】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳白色のエッセンスを得た。
【0056】
処方例5.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例2の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0057】
処方例6.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例3の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0058】
処方例7.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例4の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0059】
処方例8.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例5の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0060】
処方例9.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例6の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0061】
処方例10.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例7の混和物5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0062】
処方例11.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例8の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0063】
処方例12.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例9の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0064】
処方例13.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例10の乳化剤5.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0065】
処方例14.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例11の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0066】
処方例15.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例12の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0067】
処方例16.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例13の乳化剤組成物6.0部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0068】
処方例17.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例1の乳化剤2.0部とキサンタンガム0.5部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0069】
処方例18.乳液
処方例2のB成分中、実施例1の乳化剤5.0部に代えて実施例1の乳化剤2.0部とヒアルロン酸0.5部を用いるほかは処方例2と同様にして均質な乳液を得た。
【0070】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却した。
【0071】
A成分及びB成分をそれぞれ80℃に加温溶解後、両成分を合してヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを攪拌しながら冷却し、50℃でC成分を加えてさらに30℃まで冷却した。
【0072】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを攪拌しながら30℃以下まで冷却した。
【0073】
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却した。
【0074】
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却した。
【0075】
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0076】
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0077】
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却した。
【0078】
B成分を混合し、80℃に加温溶解後30℃まで冷却した。これにA成分を加えて充分に練合した後、減圧脱泡した。
【0079】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0080】
処方例29.乳液
処方例28のB成分中、コウジ酸2.0部に代えてL−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.2部を用いるほかは処方例28と同様にして乳液を得た。
【0081】
処方例30.乳液
処方例28のB成分中、コウジ酸2.0部に代えてL−アスコルビン酸−2−リン酸エステルマグネシウム3.0部を用いるほかは処方例28と同様にして乳液を得た。
【0082】
処方例31.乳液
処方例28のB成分中、コウジ酸2.0部に代えてアルブチン2.0部を用いるほかは処方例28と同様にして乳液を得た。
【0083】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して乳液を得た。
【0084】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して均質な乳液を得た。
【0085】
B成分を85℃まで加温して溶解し、室温まで冷却した後、これにA成分を混合溶解した液を加え、次いでC成分を添加してpHを7とした。
【0086】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して消炎鎮痛剤(クリーム)を得た。
【0087】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して抗炎症剤(クリーム)を得た。
【0088】
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。
これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して抗真菌剤(乳液)を得た。
【0089】
試験例1.乳化作用(その1)
雑穀類の乳酸菌醗酵物からなる乳化剤と、比較のため雑穀類をそのままミキサー粉砕し篩い分け(90μm、166メッシュ)して得られた微粉末について乳化作用を調べた。
[試料]
(1)実施例1、3、4、5、6、7及び8の各乳化剤
(2)ハト麦、大麦、アワ、キビ、ヒエ、大豆及び小豆の各微粉末
【0090】
【表1】
【0091】
即ち、成分4を成分3に溶解し、これに成分2及び成分5を加えて混合し、80℃に加熱した。これを、成分1の油性成分を80℃に加熱したものに加え、5000rpm×2分間の条件でホモジナイズした後、攪拌下に水冷して室温まで冷却した。ここに得られた乳化物をそれぞれ50mlのスクリュウ瓶に入れ、調製直後の乳化状態と、室温又は50℃に3カ月間保存した時の乳化状態の経時変化を目視観察し、以下の基準により評価した。
◎ :良好
○ :1カ月以上経過後に極く僅かに分離が認められる
△ :2週間〜1カ月経過後に僅かに分離が認められる
× :1週間以内に完全分離する
なお、比較試料のハト麦微粉末、アワ微粉末及び大豆微粉末の場合には、いずれも乳化物調製直後に油浮きが認められ、乳化状態は不良であった。
【0092】
[結果]
結果を表2に示す。
【表2】
【0093】
表2に示す通り、本発明の雑穀類の乳酸菌醗酵物からなる乳化剤は、いずれもすぐれた乳化作用を有し、長期間安定な乳化物を与える。これに対して、乳酸菌醗酵を行っていない雑穀類の微粉末によっては、安定な乳化物は得られない。
【0094】
試験例2.乳化作用(その2)
乳酸菌醗酵物に増粘剤を併用した場合の乳化安定性への影響を調べた。
[試験方法]
表3に示す成分組成(単位:部)からなる3種の乳化物を調製し、それらの経時変化を観察した。
【0095】
【表3】
【0096】
即ち、成分4を成分3に溶解し、これに成分5のいずれかを加えて混合した。別に、成分2と6の混合物及び成分1をそれぞれ80℃に加温後、成分1に成分2と6の混合物を加え、ヒスコトロン(5000rpm)で2分間ホモジナイズした。これに上記の成分3、4、5の混合物を加え、ヒスコトロン(5000rpm)でさらに1分間ホモジナイズした後、攪拌しながら室温まで水冷した。ここに得られた乳化物をそれぞれ50mlのスクリュウ瓶に入れ、調製直後の乳化状態と、室温又は50℃に3カ月間保存した時の乳化状態の経時変化を目視観察し、試験例1と同様の基準に従って評価した。
【0097】
[結果]
結果を表4に示す。
【表4】
【0098】
表4の結果から、乳酸菌醗酵物に増粘剤を併用した場合、得られる乳化物の安定性が一層向上することが判る。
【0099】
試験例3.皮膚刺激性
雑穀類の乳酸菌発酵物の皮膚刺激性を、化粧料の乳化剤として汎用されている成分のそれと比較した。
[試料]
下記の成分を、各々日局親水ワセリンに5%の濃度となるように練合したものを試料として用いた。
(1)実施例1の乳化剤
(2)ポリオキシエチレン(20)ソルビタンモノオレエート (比較試料a)
(3)親油型モノステアリン酸グリセリン(比較試料b)
【0100】
[試験方法]
年齢20〜50歳の成人男子5名を被験者とし、各々の上腕部内側をエタノールで拭って皮脂を除去し、該部位に、フィンチャンバーのアルミ板に各々の試料0.2gを塗布したものを貼付した。24時間後にフィンチャンバーを除去し、皮膚刺激の程度をつぎに述べる方法並びに基準により判定した。
【0101】
[判定]
パッチ除去後1時間後、24時間後及び48時間後に、貼付部位の紅斑及び浮腫の状況を、以下の「ドレイズ法による皮膚刺激性判定基準」に基づき目視判定し、被験者5名の平均値を求めた。
(紅斑)
スコア 皮膚の状態
0 : 紅斑なし
1 : 極く軽度の紅斑
2 : 明らかな紅斑
3 : 中程度から強い紅斑
4 : 深紅色の強い紅斑に軽い痂皮形成
(浮腫)
スコア 皮膚の状態
0 : 浮腫なし
1 : 極く軽度の浮腫
2 : 明らかな浮腫(周囲と明らかに区別可能)
3 : 中程度の浮腫(1mm以上の盛り上がり)
4 : 強い浮腫(さらに周囲にも広がり)
【0102】
[結果]
結果を表5に示す。
【表5】
【0103】
本試験で比較試料として用いたa、bの乳化剤は、比較的安全性が高いところから、化粧料の乳化に汎用されているものであるが、表5の結果から明らかな通り、実施例1の雑穀類の乳酸菌醗酵物からなる乳化剤は、それら汎用の乳化剤よりもさらに皮膚刺激性が少なく、安全性に極めてすぐれている。
【0104】
試験例4.モニターテスト
下記の各試料について、モニターテストにより使用感と安全性(皮膚刺激性)を評価した。
[試料]
(1)処方例2の乳液
(2)処方例2に於いて、実施例1の乳化剤5.0部に代えてポリオキシエチレン(20)ソルビタンモノオレエート2.0部を用いるほかは処方例2と同様にして得られた乳液(比較乳液)
【0105】
[試験方法]
無作為に抽出した年齢18〜50歳の女性20名を被験者とし、各乳液を1日2回(朝、晩)、5日間左上腕部にそれぞれ塗布した時の使用感及び皮膚刺激性を、下記の各項目について評価した。
(使用感)
イ.手に取った感触
ロ.塗布時の伸び
ハ.塗布時のなめらかさ
ニ.浸透性(浸透感)
ホ.塗布後の感触
(皮膚刺激性)
ヘ.塗布時の刺激
ト.塗布後の刺激
評価は、使用感については5段階評価(A:良い、B:やや良い、C:普通、D:やや悪い、E:悪い)によって、又皮膚刺激性については3段階評価(A:刺激なし、B:違和感あり、C:刺激あり)によってそれぞれ行った。
【0106】
[結果]
結果を表6及び表7に示す。
【表6】
【0107】
【表7】
【0108】
表6及び表7に示す通り、雑穀類の乳酸菌醗酵物からなる乳化剤を使用して調製された乳液は、使用感に於いて高い評価を得ており、又皮膚刺激性も認められなかった。
これに対して、合成界面活性剤を用いて得られた比較乳液は、使用感に於いて劣るだけでなく、若干の皮膚刺激性も認められた。
【発明の効果】
雑穀類の乳酸菌醗酵物からなる本発明の乳化剤は、良好な乳化力を具えると共に、低毒性でかつ皮膚刺激が極めて少ないなど人に対する安全性にすぐれ、化粧料、外用医薬品、食品など広汎な分野に於ける乳化物の調製に用いて有用である。 なかでも、化粧料や外用医薬品の乳化剤として用いた場合には、該乳酸菌醗酵物の有する高い保湿・保水能と皮膚に対する密着性の故に、得られる化粧料、外用医薬品は、皮膚に対する感触、使用感にすぐれたものとなる。
従って、本発明によれば又、上記の乳酸菌醗酵物を含んでなり、乳化安定性と生体安全性、さらには使用感の良好な化粧料及び外用医薬品が提供される。[0001]
BACKGROUND OF THE INVENTION
The present invention has a good emulsifying action, and is excellent in safety such as low toxicity and low skin irritation, and is used for the preparation of emulsions in a wide variety of product fields such as cosmetics, topical medicines, and foods. The present invention relates to a suitable emulsifier and cosmetics and topical medicines containing or using the same.
[0002]
[Prior art]
Synthetic surfactants such as polyoxyethylene alkyl ethers and sorbitan fatty acid partial esters are mainly used for emulsification of cosmetics and external medicines.
However, in the case of synthetic surfactants, irritation to the skin is unavoidable to some extent, so the amount of active agent used can be reduced as much as possible, or in some cases emulsification can be carried out without using it. Although attempts have been made, there are many cases that cause problems in terms of uniformity of emulsification and stability over time, and satisfactory results are not always obtained.
[0003]
[Problems to be solved by the invention]
On the other hand, it has been proposed to prepare a highly safe emulsion for the skin by using ingredients derived from natural products such as saponin, lecithin and stevioside as emulsifiers. There are aspects that are not necessarily sufficient in terms of stability, usability when applied to the skin, ease of production, and the like, and further improvements are required.
In order to solve the problems of the prior art, the present inventors have previously proposed that lactic acid bacteria fermented rice obtained by first fermenting rice with lactic acid bacteria has excellent emulsifying action, emulsifying stabilization action, and high biological safety. It has been clarified that it is extremely useful for emulsification of ingredients, etc., but as a result of research and search to find what can be an emulsifier among the ingredients derived from natural products, Similarly, the present invention has been completed by knowing that it has good emulsifying action and biosafety and can be used as an emulsifier in a wide range of fields such as cosmetics, topical medicines, and foods.
[0004]
[Means for Solving the Problems]
That is, the present inventionOne or more selected from barley, red beans, millet and barnyard milletLactic acid bacteria fermentation product obtained by fermenting lactic acid bacteriaSolid phase partAn emulsifier comprising the lactic acid bacteria fermentation productSolid phase partThe present invention relates to cosmetics or topical pharmaceuticals.
In the present invention, the term “cosmetics” is used to include quasi-drugs in addition to so-called cosmetics.Moreover, in the following, the solid phase part of a lactic acid bacteria fermentation product may be simply called a lactic acid bacteria fermentation product.
[0005]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, the present invention will be described in detail.
milkAs cereals to be used as fermented products of acid bacteria fermentation, for example, barley, wheat, oats, pigeons, oats, naked wheat, rye and other wheat, soy beans, black soybeans, red beans, kidney beans, handed beans, Daifuku beans, Examples include beans such as quail beans, peas beans, lentils, white flower beans, red flower beans, tiger beans, green beans, chickpeas, broad beans, tree beans, millet, millet, millet, buckwheat, buckwheat, amaranth, corn, etc. .
Among them, from the viewpoint of emulsifying ability of lactic acid bacteria fermented product or stability of raw material quality, barley, wheat and pigeons as wheat, soybeans and red beans as beans, millet, millet, Millet and corn are preferred, and barley, red beans, millet and millet are most preferred.Therefore, in the present invention, four kinds of barley, red beans, millet and Japanese millet are used..
In the present invention, it is also possible to use germinated products of the above-mentioned minor cereals, for example, germinated soybeans, germinated barley, etc. as fermented products, and lactic acid bacteria exhibiting a good emulsifying action also with those germinated products. A fermented product can be obtained.
In preparing the lactic acid bacteria fermentation product of the present invention, it is common to use any one of the seeds of the above-mentioned minor cereals, but in some cases, two or more seeds may be mixed and used. .
[0006]
Examples of lactic acid bacteria used for the fermentation of millet include Lactobacillus plantarum, L. brevis, L. brevis, L. casei, Lactobacillus cellobiosus, Lactobacillus. Lactobacillus plantarum (L. vaccinostercus), Streptococcus faecalis (Bacillus coagulans), etc., but from the viewpoint of the emulsifying capacity of the resulting lactic acid bacteria fermentation product, Lactobacillus plantarum (Lactobacillus plantarum) or Streptococcus The use of (Streptococcus faecalis) is particularly preferred.
[0007]
Fermentation of minor cereals with these lactic acid bacteria is performed, for example, as follows.
First, the cereal seeds are subjected to appropriate means such as washing with water and ethanol treatment to remove miscellaneous bacteria that hinder lactic acid bacteria fermentation. The seeds are immersed in 1 to 5 times the amount of purified water, and 1 to 4% by weight of saccharide and 10 lactic acid bacteria are added thereto.7 -108 Each piece / ml is added and fermented for 2 to 10 days under anaerobic conditions near the optimum fermentation temperature of the lactic acid bacteria used.
As the saccharide, glucose, fructose, galactose, sucrose and the like are used, and among them, the use of fructose is most preferable. Further, yeast extract, malt extract or the like may be used instead of sugar.
[0008]
The liquid containing the cereal lactic acid bacteria fermented product obtained by the above fermentation process may be subjected to the grinding process as it is, may be concentrated if necessary, and blended into cosmetics, etc. The lactic acid bacteria fermentation product is separated from the fermentation broth, washed with water, adjusted for moisture if necessary, pulverized using an appropriate pulverizing means such as mixer pulverization, roll pulverization, airflow pulverization, and if necessary, dried. Furthermore, sieving is performed and used as an emulsifier for cosmetics and the like.
[0009]
When the emulsifier of the present invention consisting of a cereal lactic acid bacteria fermentation product obtained as described above is blended or applied to cosmetics, etc., the fermentation product has sufficient emulsifying power by itself, and the resulting emulsion is Although the emulsion stability that can be sufficiently satisfied in practical use is shown, the stability of the emulsion can be further improved by further using a thickener in combination with the fermented product.
[0010]
Here, as the thickener, those usually used in cosmetics and the like can be used. Specifically, for example, algae, agar, carrageenan, fucoidan and other brown algae, green algae or red algae-derived components; pectin, Polysaccharides such as locust bean gum; Gums such as xanthan gum, tragacanth gum and guar gum; Cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; Synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer, etc. Molecules; hyaluronic acid or derivatives thereof, polyglutamic acid or derivatives thereof, and the like.
Among them, from the viewpoint of emulsion stability, and also from the viewpoint of not impairing the high biological safety that is a feature of the lactic acid bacteria fermentation product of the present invention, hyaluronic acid or a derivative thereof, polyglutamic acid or a derivative thereof, xanthan gum or tragacanth gum In addition, components derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan and fucoidan can also be suitably used.
[0011]
When these thickeners are used in combination, the amount of use varies depending on the type of thickener used, but generally ranges from 1 to 100 parts by weight of solids relative to 100 parts by weight of solids of lactic acid bacteria fermentation products. Preferably, the amount is in the range of 5 to 50 parts by weight, and the optimum one is selected from this range in consideration of the use of the emulsion, required performance, and the like.
[0012]
In the combined use with the lactic acid bacteria fermentation product, the thickener may be used by mixing with the lactic acid bacteria fermentation product in advance at a predetermined ratio, and when emulsifying cosmetics etc. using the lactic acid bacteria fermentation product, You may make it add to an emulsification system before or after addition or simultaneously with this fermented material. In some cases, it can be added after emulsification.
[0013]
The emulsifier comprising the cereal lactic acid bacteria fermented product of the present invention has a good emulsifying action, gives an emulsion with high stability, is excellent in safety to the human body such as low toxicity and extremely little irritation to the skin, It is useful for the preparation of emulsions in a wide range of fields such as cosmetics, topical medicines, foods and agricultural chemicals.
In particular, when used as an emulsifier for cosmetics and topical pharmaceuticals, the skin feel and feel of the resulting cosmetics, etc. are extremely high due to the high water retention and moisture retention of the lactic acid bacteria fermentation product and the adhesion to the skin. There is also an advantage of being good.
Therefore, according to this invention, the cosmetics and external medicine which were excellent in the emulsification stability and biological safety, and also the usability | use_conditions are provided including the lactic-acid-bacteria fermented product of the above-mentioned minor grains.
[0014]
Examples of the cosmetics of the present invention comprising cereal lactic acid bacteria fermented products include basic cosmetics such as emulsions, creams, lotions, essences and packs; makeup cosmetics such as lipsticks, foundations, liquid foundations and makeup press powders. Cosmetics for cleansing such as facial cleansers, shampoos and rinses; hair cosmetics such as hair treatments, conditioners, hair creams, hair dyes and hair stylings; oral cosmetics such as toothpastes and mouthwashes; pharmaceutical parts comprising bath preparations and various dosage forms Examples include foreign products.
Moreover, as an external pharmaceutical preparation of this invention which mix | blends the lactic-acid-bacteria fermented material of a minor cereal, there exist a cream, milky lotion, lotion etc., for example.
[0015]
The amount of cereal lactic acid bacteria fermented product of the present invention when blended in cosmetics varies depending on the type of cosmetics, etc., for example, in the case of basic cosmetics, makeup cosmetics, hair cosmetics and quasi drugs. If present, it is generally 0.5 to 20% by weight (as the solid content of the lactic acid bacteria fermentation product, the same shall apply hereinafter), preferably in the range of 2 to 10% by weight, and in the case of cleaning cosmetics, generally 1 to 30% by weight, The range is preferably 5 to 20% by weight, and in the case of oral cosmetics, it is generally 0.5 to 20% by weight, preferably 2 to 10% by weight.
For example, in the case of a cream, milky lotion, or lotion, the amount to be added to the external medicine is generally 0.5 to 20% by weight, preferably 2 to 10% by weight.
If a thickener is used in combination when blending the lactic acid bacteria fermented product, the blended amount of the lactic acid bacteria fermented product can be reduced to 40 to 80% in the case of the above single use.
[0016]
In addition, when blending lactic acid bacteria fermentation product of milled cereals of the present invention in cosmetics, etc., when one or more kinds selected from hydrophilic substances, in particular sugars and glycols, are mixed in advance with the lactic acid bacteria fermentation product, The familiarity and dispersibility of the lactic acid bacteria fermented product with respect to water are improved, and blending into cosmetics and the like is facilitated.
[0017]
In this case, examples of the saccharide include monosaccharides such as glucose, fructose, arabinose, and galactose; disaccharides such as sucrose, lactose, maltose, and trehalose; oligosaccharides such as fructooligosaccharide, xylooligosaccharide, and malto-oligosaccharide; sorbitol, maltitol, Sugar alcohols such as xylitol can be used.
[0018]
Examples of glycols include glycerin, propylene glycol, 1,3-butylene glycol, and polyethylene glycol.
[0019]
Among these saccharides and / or glycols (hereinafter sometimes referred to as admixed components), the use of saccharides is preferable from the viewpoint of improving the familiarity / dispersibility of lactic acid bacteria fermentation products with water. Most preferred is the use of alcohols. .
[0020]
In addition, the dispersibility improving effect is more effectively expressed when the admixture of lactic acid bacteria fermentation product and saccharide and / or glycols is wet with water or liquid substance. When used, the resulting mixture should be in a wet state with a moisture content in the range of 10 to 40% by weight, particularly 15 to 30% by weight, by a method of blending them into the lactic acid bacteria fermentation product in the form of an aqueous solution. Is preferred.
On the other hand, when using glycols such as glycerin and 1,3-butylene glycol that are liquid at room temperature, the admixture can be in a wet state based on the properties of the glycol itself. Although this is not always necessary, it may be used in some cases.
[0021]
The amount of saccharides or glycols to be added to the lactic acid bacteria fermentation product is generally 5 to 50 parts by weight, preferably 10 to 40 parts by weight, based on 100 parts by weight of the lactic acid bacteria fermentation product (solid content). The range is parts by weight.
[0022]
As a method for preparing a mixture of a lactic acid bacteria fermentation product and sugars and / or glycols, a method of adding a predetermined amount of the mixing component to the lactic acid bacteria fermentation product to obtain a uniform mixture using an appropriate mixing means is usually used. There is no particular limitation as long as it is performed according to the method, but when using a solid substance at room temperature such as a monosaccharide or sugar alcohol as an admixture component, the effect of improving the dispersibility of the admixture can be expressed more effectively. Adjust the moisture content of the admixture to the desired value by mixing the admixture components with the lactic acid bacteria fermentation product in the form of an aqueous solution, or by adding water after mixing in some cases in some cases. It is preferable to do.
[0023]
When blending an admixture obtained as described above into cosmetics, etc., as a result of improving the familiarity and dispersibility of water, it has already been found that the workability of blending and the homogeneity of the resulting product are greatly improved. As described above, the cereal lactic acid bacteria fermentation product of the present invention shows acidity when dispersed and dissolved in water due to the characteristics of lactic acid bacteria fermentation. There may be cases where a summing process is required.
An alkaline substance may be further added to the mixture in order to eliminate the complexity of the process and to improve the workability and handleability.
[0024]
In this case, examples of the alkaline substance include alkali metal or alkaline earth metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide; weak acid alkalis such as carbonic acid, citric acid, and phosphoric acid. Metal salts; amines such as ethanolamine, diethanolamine, triethanolamine and isopropanolamine; basic amino acids such as arginine, lysine and histidine; ammonia water, aminomethylpropanol and aminomethylpropanediol.
[0025]
The blending amount of these alkaline substances varies depending on the type of the alkaline substance used, but generally, the amount is such that the pH of the 10% by weight aqueous dispersion or aqueous solution of the composition is in the range of 5.5 to 7.5. Good.
[0026]
When preparing cosmetics and external medicines containing the cereal lactic acid bacteria fermentation product of the present invention, as its constituents, components usually used in cosmetics, such as oily ingredients, humectants, thickeners, antiseptics, Bactericides, powder components, ultraviolet absorbers, antioxidants, pigments, fragrances, physiologically active components, drugs, and the like can be used as appropriate. If necessary, a surfactant may be used in combination.
[0027]
Here, examples of the oil component include olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Oils derived from plants such as macadamia nut oil and plant-derived squalane; Fats derived from animals such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; liquid paraffin, petrolatum, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Isopropyl, me Butyl phosphate, 2-ethylhexyl glycerides, higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the synthetic esters and synthetic triglycerides such like.
[0028]
Examples of humectants include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and sugars such as trehalose, lactic acid bacteria fermented rice, hyaluronic acid and Examples thereof include derivatives thereof, NMF-related substances, lactic acid, urea, higher fatty acid octyldodecyl, beech extract, seaweed extract, seafood-derived collagen and derivatives thereof, various amino acids and derivatives thereof.
[0029]
Examples of thickeners include, for example, brown algae such as alginic acid, agar, carrageenan, fucoidan, green algae or red algae-derived components, extract of sand cucumber, pectin, locust bean gum, polysaccharides such as aloe polysaccharide, xanthan gum, tragacanth gum, guar gum, etc. Synthetic polymers such as gums, cellulose derivatives such as carboxymethylcellulose, hydroxyethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives, polyglutamic acid and its derivatives, etc. Is mentioned.
[0030]
Examples of the antiseptic / bactericidal agent include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzaza chloride Luconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodenyl urea), 1,2-pentanediol, various essential oils, bark dry matter, and the like.
[0031]
Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, silk powder, cereals (rice, Wheat, corn, millet, etc.) and beans (soybeans, red beans, etc.) powder.
[0032]
Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
[0033]
Antioxidants include, for example, butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and its derivatives, various polyphenols, beech extract, rice extract and the like.
[0034]
Examples of physiologically active ingredients include whitening ingredients such as t-cycloamino acid derivatives, kojic acid and its derivatives, ascorbic acid and its derivatives, arbutin and its derivatives, ellagic acid and its derivatives, resorcinol derivatives, Sakuhakuhi extract, yukinoshita extract , Rice bran extract, rice bran extract hydrolyzate, white coconut hydrolyzate extract, murasakikibu extract, seaweed extract such as kombu, seaweed extract such as sea cucumber, linoleic acid and its derivatives or processed products (for example, Liposomal linoleic acid, etc.), 2,5-dihydroxybenzoic acid derivatives, etc. are skin aging prevention / skin roughening components, such as collagen derived from animals or fish, nicotinic acid and its derivatives, glycyrrhizic acid and its derivatives (dipotassium salt, etc.) , T-cycloamino acid derivatives, vitamin A and its derivatives Herbal extracts such as vitamin E and derivatives thereof, allantoin, α-hydroxy acids, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extract, licorice extract, pearl barley extract, chamomile extract, carrot extract, aloe extract, Examples include rice extract hydrolyzate, rice bran extract hydrolyzate, rice fermented extract, honey beet extract, seaweed extract such as sea cucumber, and sow extract.
[0035]
Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate, kojic acid ethers, kojic acid sugar derivatives such as kojic acid glucoside, etc. However, as the ascorbic acid derivatives, for example, L-ascorbic acid-2-phosphate sodium, L-ascorbic acid-2-phosphate magnesium, L-ascorbic acid-2-sulfate sodium, L-ascorbic acid-2 -Ascorbic acid ester salts such as magnesium sulfate, L-ascorbic acid-2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O-α) -D-glucopyranosyl-L-ascorbine Acid) ascorbic acid sugar derivatives, acylated 6-positions of these ascorbic acid sugar derivatives (acyl groups are hexanoyl, octanoyl, decanoyl, etc.), L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetra Examples of L-ascorbic acid tetrafatty acid esters such as lauric acid ester include resorcinol derivatives such as 4-n-butylresorcinol and 4-isoamylresorcinol, and examples of 2,5-dihydroxybenzoic acid derivatives include 2, 5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid and the like are nicotinic acid derivatives such as nicotinic acid amide and benzyl nicotinate as vitamin E derivatives. For example Glutamic E nicotinate, vitamin E linoleate and the like, as the α- hydroxy acids such as lactic acid, malic acid, succinic acid, citric acid, α- hydroxy octanoic acid.
[0036]
Anti-inflammatory analgesics and antipruritic agents such as ethyl aminobenzoate, indomethacin, heparin sodium, methyl salicylate; corticosteroid anti-inflammatory agents such as hydrocortisone, dexamethasone, fluocinolone acetonide, prednisolone; benzalkonium chloride, chloride Bactericides such as benzethonium, chlorhexidine and sulfadiazine; antibiotic bactericides such as erythromycin, tetracycline, chloramphenicol and tricomycin; antifungal agents such as clotrimazole, tolnaftate, miconazole nitrate and ketoconazole; diphenhydramine and chlorpheniramine maleate , Antihistamines such as istipendil hydrochloride and clemastine fumarate; urea, salicylic acid, vitamin A, vitamin E, vitamin C, vitamin B6Such as a rough skin improving agent
[0037]
As described above, the surfactant does not necessarily need to be used in combination. However, if used in combination, the active agent having excellent biological safety such as sucrose fatty acid ester, lecithin and its derivatives, and enzyme-treated stevia. It is preferable to use a small amount.
[0038]
Next, the present invention will be described more specifically with reference to Examples, Formulation Examples (Cosmetics and External Drug Examples), and Test Examples, but the present invention is not limited thereto. In the following, all parts are by weight, and all% are by weight.
[0039]
Example 1. Preparation of emulsifier (1)
1 kg of wheat is immersed in 70% ethanol overnight for sterilization, and then the wheat is separated by filtration, and then the operation of adding 2 L of boiled water and washing it is repeated three times to fully remove the ethanol. Removed.
After adding 3 L of boil-sterilized 0.1% yeast extract solution to sterilized pigeon, it was pre-cultured in GYP medium (37 ° C., 3 days), and the lactic acid bacteria (S.faecalis) culture solution The concentration of lactic acid bacteria is 108A quantity of 1 ml / 0.1% yeast extract was added and cultured at 37 ° C. for 3 days in a nitrogen atmosphere.
After completion of the culture, coarsely filtered through a wire mesh to collect the lactic acid bacteria fermented products of pigeons, washed this with running water, thoroughly washed off the attached culture solution, and then the moisture content at 60 ° C. under ventilation. Was dried to about 15% or less. Next, the dried product was pulverized by a mixer and then sieved (90 μm, 166 mesh) to obtain a lactic acid bacteria fermentation product of pigeon as a fine powder (yield 920 g, moisture content 12.5%).
[0040]
Example 2 Preparation of emulsifier (2)
As a lactic acid bacterium, L. The same operation as in Example 1 was performed except that plantalum was used, and a lactic acid bacteria fermentation product of pigeon was obtained as a fine powder (yield 910 g, moisture content 12.4%).
[0041]
Example 3 FIG. Preparation of emulsifier (3)
The same operation as in Example 1 was performed except that barley was used in place of the wheat, and a barley lactic acid bacteria fermentation product was obtained as a fine powder (yield 580 g, moisture content 12.0%).
[0042]
Example 4 Preparation of emulsifier (4)
The same operation as in Example 1 was carried out except that millet was used in place of the pigeons to obtain a millet lactic acid bacteria fermentation product as a fine powder (yield 880 g, moisture content 12.8%).
[0043]
Embodiment 5 FIG. Preparation of emulsifier (5)
Except for using millet instead of the wheat, the same operation as in Example 1 was performed to obtain a milled lactic acid bacteria fermentation product as a fine powder (yield 890 g, moisture content 12.4%).
[0044]
Example 6 Preparation of emulsifier (6)
The same operation as in Example 1 was carried out except that the barley was used in place of the wheat, and a barley lactic acid bacteria fermentation product was obtained as a fine powder (yield 900 g, moisture content 12.0%).
[0045]
Example 7 Preparation of emulsifier (7)
The same operation as in Example 1 was performed except that soybean was used in place of the wheat, and a soybean lactic acid bacteria fermentation product was obtained as a fine powder (yield 920 g, moisture content 13.2%).
[0046]
Example 8 FIG. Preparation of emulsifier (8)
The same operation as in Example 1 was carried out except that red beans were used instead of pigeons, and a lactic acid bacteria fermentation product of red beans was obtained as a fine powder (yield 780 g, moisture content 12.5%).
[0047]
Example 9 Preparation of emulsifier (9)
The soybeans were washed with water, immersed in 3 times the amount of water overnight, and then drained. This was kept in a moist state at 30 ° C. for 2 days to germinate, and the germinated soybean was dried at 60 ° C. overnight.
1 kg of this dried germinated soybean is soaked overnight in 70% ethanol for sterilization, and then the germinated soybean is separated by filtration, and then the operation of adding 2 L of boiled sterilized water and washing it is repeated three times. Fully removed.
Lactic acid germination (S.faecalis) culture that had been pre-cultured in GYP medium (37 ° C, 3 days) after adding 3 L of boil-sterilized 0.1% yeast extract solution to sterilized germinated soybean The solution is lactic acid bacteria concentration 108A quantity of 1 ml / 0.1% yeast extract was added and cultured at 37 ° C. for 3 days in a nitrogen atmosphere.
After completion of the cultivation, the lactic acid bacteria fermentation product of germinated soybeans is separated by coarse filtration through a wire mesh, washed with running water, and the attached culture solution is thoroughly washed away. Was dried to about 15% or less. Next, the dried product was pulverized by a mixer and sieved (90 μm, 166 mesh) to obtain a lactic acid bacteria fermentation product of germinated soybeans as a fine powder (yield 890 g, moisture content 13.5%).
[0048]
Example 10 Preparation of emulsifier (10)
The same operation as in Example 9 was performed except that barley was used in place of soybeans, and a lactic acid bacteria fermentation product of germinated barley was obtained as a fine powder (yield 880 g, moisture content 12.8%).
[0049]
Example 11 Preparation of emulsifier composition (1)
200 g of maltitol liquid (70% maltitol aqueous solution) was added to 800 g of fine powder of lactic acid bacteria fermented by wheat as obtained in the same manner as in Example 1, and kneaded and mixed with a kneader. A product was obtained (moisture content 14.6%).
[0050]
Example 12 Preparation of emulsifier composition (2)
A uniform mixture was obtained in the same manner as in Example 11 except that 200 g of glycerin was used instead of 200 g of the maltitol solution (water content 12.4%).
[0051]
Example 13 Preparation of emulsifier composition (3)
200 g of maltitol solution and 15 g of arginine were added to 785 g of fine powder of lactic acid bacteria fermentation product of pigeon wheat obtained by the same operation as in Example 1, and kneaded and mixed with a kneader to obtain a uniform mixture. (Moisture content 15.1%).
[0052]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 ° C., component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous cream.
[0053]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After this was cooled to 50 ° C., component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0054]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less, and the milky white lotion was obtained.
[0055]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 ° C., component C was added and stirred and mixed, and further cooled to 30 ° C. or lower to obtain a milky white essence.
[0056]
Formulation Example 5 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 2 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0057]
Formulation Example 6 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 3 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0058]
Formulation Example 7 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 4 was used instead of 5.0 parts of the emulsifier of Example 1 in the component B of Formulation Example 2.
[0059]
Formulation Example 8 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 5 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0060]
Formulation Example 9 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 6 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0061]
Formulation Example 10 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the mixture of Example 7 was used in Component B of Formulation Example 2 instead of 5.0 parts of the emulsifier of Example 1.
[0062]
Formulation Example 11 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 8 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0063]
Formulation Example 12. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 9 was used instead of 5.0 parts of the emulsifier of Example 1 in the component B of Formulation Example 2.
[0064]
Formulation Example 13 Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 5.0 parts of the emulsifier of Example 10 was used in Component B of Formulation 2 instead of 5.0 parts of the emulsifier of Example 1.
[0065]
Formulation Example 14. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 11 was used in Component B of Formulation Example 2 instead of 5.0 parts of the emulsifier of Example 1.
[0066]
Formulation Example 15. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 12 was used instead of 5.0 parts of the emulsifier of Example 1 in Component B of Formulation Example 2.
[0067]
Formulation Example 16. Latex
A homogeneous emulsion was obtained in the same manner as in Formulation Example 2, except that 6.0 parts of the emulsifier composition of Example 13 was used in Component B of Formulation Example 2 instead of 5.0 parts of the emulsifier of Example 1.
[0068]
Formulation Example 17. Latex
A homogeneous emulsion was prepared in the same manner as in Formulation Example 2 except that 2.0 parts of the emulsifier of Example 1 and 0.5 part of xanthan gum were used in the B component of Formulation Example 2 instead of 5.0 parts of the emulsifier of Example 1. Obtained.
[0069]
Formulation Example 18. Latex
A homogeneous emulsion in the same manner as in Formulation Example 2, except that 2.0 parts of the emulsifier of Example 1 and 0.5 part of hyaluronic acid are used in the component B of Formulation Example 2 instead of 5.0 parts of the emulsifier of Example 1. Got.
[0070]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less.
[0071]
The components A and B were each heated and dissolved at 80 ° C., and then both components were combined and homogenized with Hiscotron (5000 rpm) for 2 minutes. This was cooled while stirring, and C component was added at 50 ° C. and further cooled to 30 ° C.
[0072]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
This was cooled to 30 ° C. or lower while stirring.
[0073]
Component C was mixed and pulverized with a pulverizer. The component B was mixed, and the pulverized component C was added thereto and uniformly dispersed in a colloid mill. The components A and B and C dispersed uniformly were each heated to 80 ° C., and then the components A were added to the components B and C while stirring, and further homogenized with Hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 degreeC, D component was added and stirred and mixed, and also it cooled to 30 degrees C or less, stirring further.
[0074]
Component C was mixed and pulverized with a pulverizer. The component B was mixed, and the pulverized component C was added thereto and uniformly dispersed in a colloid mill. The components A and B and C dispersed uniformly were each heated to 80 ° C., and then the components A were added to the components B and C while stirring, and further homogenized with Hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 degreeC, D component was added and stirred and mixed, and also it cooled to 30 degrees C or less, stirring further.
[0075]
After each component A and component B was heated to 80 ° C. and uniformly dissolved, component B was added to component A, and stirring was continued to cool to room temperature.
[0076]
After each component A and component B was heated to 80 ° C. and uniformly dissolved, component B was added to component A, and stirring was continued to cool to room temperature.
[0077]
After each component A and component B was heated to 80 ° C. and uniformly dissolved, component B was added to component A, and stirring was continued to cool to room temperature.
[0078]
The component B was mixed, heated to 80 ° C and dissolved, and then cooled to 30 ° C. The component A was added to this and kneaded sufficiently, and then degassed under reduced pressure.
[0079]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After this was cooled to 50 ° C., component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0080]
Formulation Example 29. Latex
In the component B of formulation example 28, instead of using 2.0 parts of kojic acid, the emulsion was prepared in the same manner as in formulation example 28 except that 2.0 parts of L-ascorbic acid-2-glucoside and 0.2 parts of potassium hydroxide were used. Obtained.
[0081]
Formulation Example 30. Latex
An emulsion was obtained in the same manner as in Formulation Example 28 except that 3.0 parts of L-ascorbic acid-2-phosphate magnesium was used in Component B of Formulation Example 28 instead of 2.0 parts of kojic acid.
[0082]
Formulation Example 31. Latex
An emulsion was obtained in the same manner as in Formulation Example 28 except that 2.0 parts of arbutin was used in the B component of Formulation Example 28 instead of 2.0 parts of kojic acid.
[0083]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less, and obtained the emulsion.
[0084]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After this was cooled to 50 ° C., component C was added and mixed with stirring, and further cooled to 30 ° C. or lower to obtain a homogeneous emulsion.
[0085]
The component B was heated to 85 ° C. to dissolve and cooled to room temperature, and then the solution in which the component A was mixed and dissolved was added thereto, and then the component C was added to adjust the pH to 7.
[0086]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After this was cooled to 50 ° C., component C was added and stirred and mixed, and further cooled to 30 ° C. or lower to obtain an anti-inflammatory analgesic (cream).
[0087]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 ° C., component C was added and stirred and mixed, and further cooled to 30 ° C. or lower to obtain an anti-inflammatory agent (cream).
[0088]
After each component A and component B were heated to 80 ° C. or higher, the component B was added to the component A and stirred, and further homogenized with Hiscotron (5000 rpm) for 2 minutes.
After cooling this to 50 degreeC, C component was added and stirred and mixed, and also it cooled to 30 degrees C or less, and obtained the antifungal agent (milky lotion).
[0089]
Test Example 1 Emulsifying action (Part 1)
MiscellaneousThe emulsification effect was examined on an emulsifier composed of a lactic acid bacteria fermentation product of cereals and a fine powder obtained by pulverizing and milling cereals as they were for comparison and sieving (90 μm, 166 mesh).
[sample]
(1) RealEach emulsifier of Examples 1, 3, 4, 5, 6, 7 and 8
(2)Fine powders of barley, barley, millet, millet, millet, soybeans and red beans
[0090]
[Table 1]
[0091]
That is, Component 4 was dissolved in Component 3, Component 2 and Component 5 were added thereto, mixed, and heated to 80 ° C. This was added to the oily component of component 1 heated to 80 ° C., homogenized under the condition of 5000 rpm × 2 minutes, and then cooled to room temperature by water cooling with stirring. Each of the emulsions obtained here is put into a 50 ml screw bottle, and the time-dependent change of the emulsified state immediately after preparation and the emulsified state when stored at room temperature or 50 ° C. for 3 months is visually observed and evaluated according to the following criteria: did.
: Good
○: Very little separation after more than 1 month
Δ: Slight separation is observed after 2 weeks to 1 month
×: Complete separation within 1 week
In addition, in the case of the comparison samples of the fine wheat powder, millet powder and soybean fine powder, oil floating was observed immediately after the preparation of the emulsion, and the emulsified state was poor.
[0092]
[result]
The results are shown in Table 2.
[Table 2]
[0093]
As shown in Table 2, the emulsifiers comprising the cereal lactic acid bacteria fermentation product of the present invention all have an excellent emulsifying action and give an emulsion that is stable for a long period of time. On the other hand, a stable emulsion cannot be obtained depending on the fine powder of millet not subjected to lactic acid bacteria fermentation.
[0094]
Test Example 2 Emulsifying action (part 2)
The effect on emulsification stability when a thickener was used in combination with a lactic acid bacteria fermentation product was examined.
[Test method]
Three types of emulsions having the component composition (unit: part) shown in Table 3 were prepared, and their changes with time were observed.
[0095]
[Table 3]
[0096]
That is, component 4 was dissolved in component 3, and any of component 5 was added and mixed. Separately, the mixture of components 2 and 6 and component 1 were each heated to 80 ° C., then the mixture of components 2 and 6 was added to component 1 and homogenized for 2 minutes with Hiscotron (5000 rpm). A mixture of the above components 3, 4, and 5 was added thereto, and the mixture was further homogenized with Hiscotron (5000 rpm) for 1 minute, and then cooled to room temperature with stirring. Each of the emulsions obtained here is put into a 50 ml screw bottle, and the time-dependent changes in the emulsified state immediately after preparation and the emulsified state when stored at room temperature or 50 ° C. for 3 months are visually observed, as in Test Example 1. Evaluation was performed according to the criteria.
[0097]
[result]
The results are shown in Table 4.
[Table 4]
[0098]
From the results in Table 4, it can be seen that when a thickener is used in combination with the lactic acid bacteria fermentation product, the stability of the resulting emulsion is further improved.
[0099]
Test Example 3 Skin irritation
MilletThe skin irritation of the lactic acid bacteria fermented product was compared with that of a component widely used as an emulsifier for cosmetics.
[sample]
Each of the following components was kneaded with JP NP hydrophilic petrolatum to a concentration of 5% and used as a sample.
(1) Emulsification of Example 1Agent
(2) Polyoxyethylene (20) sorbitan monooleate (Comparative sample a)
(3) Lipophilic glyceryl monostearate (Comparative sample b)
[0100]
[Test method]
Five adult males aged 20 to 50 years were used as subjects, the inner side of each upper arm was wiped with ethanol to remove sebum, and 0.2 g of each sample was applied to the aluminum plate of the fin chamber. Affixed. After 24 hours, the fin chamber was removed, and the degree of skin irritation was determined by the method and criteria described below.
[0101]
[Judgment]
After 1 hour, 24 hours and 48 hours after removing the patch, the state of erythema and edema at the applied site was visually determined based on the following “skin irritation criteria by dreze method”, and the average value of 5 subjects was calculated. Asked.
(Erythema)
Score Skin condition
0: No erythema
1: Extremely mild erythema
2: Clear erythema
3: Moderate to strong erythema
4: Light crust formation on deep crimson erythema
(edema)
Score Skin condition
0: No edema
1: Extremely mild edema
2: Clear edema (distinguishable from surroundings)
3: Moderate edema (swelling of 1 mm or more)
4: Strong edema (further spreads around)
[0102]
[result]
The results are shown in Table 5.
[Table 5]
[0103]
A and b used as comparative samples in this testEmulsificationThe agent is widely used for emulsification of cosmetics because of its relatively high safety, but as is apparent from the results in Table 5,Miscellaneous cereals of Example 1Emulsifiers made from fermented lactic acid bacteriaGeneral purposeIt has less skin irritation than emulsifiers and is extremely safe.
[0104]
Test Example 4 Monitor test
For each of the following samples, the feeling of use and safety (skin irritation) were evaluated by a monitor test.
[sample]
(1) Milk of Formulation Example 2liquid
(2) In Formulation Example 2, obtained in the same manner as Formulation Example 2, except that 2.0 parts of polyoxyethylene (20) sorbitan monooleate was used instead of 5.0 parts of the emulsifier of Example 1. Emulsion (comparative emulsion)
[0105]
[Test method]
Twenty women aged 18 to 50 years randomly extracted were used as subjects, and the feeling of use and skin irritation when each emulsion was applied to the left upper arm twice a day (morning and evening) for 5 days, The following items were evaluated.
(Feeling of use)
I. The feel of the hand
B. Elongation during application
C. Smoothness during application
D. Penetration (penetration)
E. Feel after application
(Skin irritation)
F. Stimulation during application
G. Irritation after application
Evaluation is based on a five-step evaluation (A: good, B: slightly good, C: normal, D: slightly bad, E: bad), and skin irritation (A: no irritation). B: Uncomfortable, C: Stimulated).
[0106]
[result]
The results are shown in Tables 6 and 7.
[Table 6]
[0107]
[Table 7]
[0108]
As shown in Table 6 and Table 7,MilletThe emulsion prepared by using an emulsifier made of a fermented product of lactic acid bacteria obtained high evaluation in use feeling and no skin irritation was observed.
On the other hand, the comparative emulsion obtained using the synthetic surfactant was not only inferior in the feeling of use but also had some skin irritation.
【The invention's effect】
The emulsifier of the present invention comprising a cereal lactic acid bacteria fermentation product has a good emulsifying power, is low in toxicity and has extremely low skin irritation, and is excellent in safety to humans. It is useful for the preparation of emulsions in the field. Above all, when used as an emulsifier for cosmetics and external medicines, the cosmetics and external medicines obtained are the skin feel and use because of the high moisturizing / water-retaining ability and adhesion to the skin of the lactic acid bacteria fermentation product. It will be excellent.
Therefore, according to the present invention, there are also provided cosmetics and external medicines comprising the above-mentioned lactic acid bacteria fermented product and having good emulsification stability, biosafety, and good usability.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002302998A JP4674286B2 (en) | 2002-10-17 | 2002-10-17 | Emulsifiers and cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002302998A JP4674286B2 (en) | 2002-10-17 | 2002-10-17 | Emulsifiers and cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004137196A JP2004137196A (en) | 2004-05-13 |
| JP4674286B2 true JP4674286B2 (en) | 2011-04-20 |
Family
ID=32450909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002302998A Expired - Lifetime JP4674286B2 (en) | 2002-10-17 | 2002-10-17 | Emulsifiers and cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4674286B2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4693623B2 (en) * | 2005-03-07 | 2011-06-01 | 共栄化学工業株式会社 | Cosmetics |
| GB0513193D0 (en) * | 2005-06-29 | 2005-08-03 | Quest Int Serv Bv | Improvements in skin and hair care |
| JP4795841B2 (en) * | 2006-04-24 | 2011-10-19 | 森下仁丹株式会社 | Germinated barley fermented product |
| KR101242442B1 (en) | 2011-06-21 | 2013-03-12 | 주식회사 마크로케어 | Cosmetic Composition Comprising Extracts of Fermented Setaria italica |
| JP2013116086A (en) * | 2011-12-05 | 2013-06-13 | Taiyo Corp | Germinated soybean fermented composition |
| KR101449282B1 (en) | 2013-05-14 | 2014-10-08 | 가천대학교 산학협력단 | Composition for improving skin wrinkle and skin moisturing comprising Barley fermented by Pichia jadinii and Aureobasidium pullulans bacteria |
| CN111166701B (en) * | 2018-11-12 | 2022-09-16 | 株式会社资生堂 | Composition for external application to skin |
| KR102111058B1 (en) * | 2019-07-02 | 2020-05-15 | 주식회사 아미코스메틱 | A cosmetic composition for skin moisturizing comprising an extract of plant-derived lactobacillus brevis (ami-1109) femented barley |
| CN111467286B (en) * | 2020-05-15 | 2022-07-01 | 万京创科(广州)生物科技有限公司 | Millet compound fermentation product and preparation method and application thereof |
| KR102226131B1 (en) * | 2020-10-30 | 2021-03-10 | 주식회사 하이솔 | Composition for skin moisturizing comprising extract of fermented Setaria italica as effective component |
-
2002
- 2002-10-17 JP JP2002302998A patent/JP4674286B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004137196A (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3711377B2 (en) | Emulsifier, emulsified cosmetic and production method thereof | |
| KR101217382B1 (en) | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE | |
| JP6599607B2 (en) | Antioxidants, skin cosmetics and hair cosmetics | |
| JP5129440B2 (en) | Fermented plant and cosmetics containing the same | |
| JP4734093B2 (en) | Cosmetics | |
| JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
| JP4693623B2 (en) | Cosmetics | |
| JP5780706B2 (en) | Whitening cosmetics | |
| JP4674286B2 (en) | Emulsifiers and cosmetics | |
| JP2009179643A (en) | Cosmetics | |
| JP5020475B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| JP5649284B2 (en) | Emulsifiers and cosmetics | |
| JP2006143670A (en) | Skin lotion | |
| JP2001212445A (en) | Emulsifying agent | |
| JP2004097999A (en) | Emulsifier and cosmetic | |
| JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| JP2016166141A (en) | Cosmetics | |
| JP6362836B2 (en) | emulsifier | |
| JP4769153B2 (en) | Cosmetics | |
| JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP2021185879A (en) | Yeast culture extract and skin preparation containing the same | |
| JP4773670B2 (en) | Elastin-like agent and cosmetics containing the same | |
| JP2019069919A (en) | Gelatinous composition | |
| JP2026023584A (en) | Epidermal thinning inhibitor and epidermal barrier function improver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051013 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20061215 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070110 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070312 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070508 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101105 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140204 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4674286 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |